Superoxide dismutase: a cellular protective enzyme in bowel ischemia

Area of Science:

• Biochemistry
• Pathophysiology
• Surgical Research

Background:

• Ischemic bowel injury is a serious condition.
• The free-radical anion superoxide (O-2) is implicated in its pathogenesis.
• Superoxide dismutase (SOD) enzymatically converts O-2.

Purpose of the Study:

• To evaluate the protective role of SOD against ischemic bowel injury.
• To assess the impact of aminophylline (AMN), a potential O-2 generator, on ischemic bowel injury.
• To investigate the combined effect of AMN and SOD.

Main Methods:

• Weaning rats underwent superior mesenteric artery occlusion for 1 minute.
• Groups received no treatment, aminophylline (AMN), superoxide dismutase (SOD), or both.
• Outcomes included bowel infarction, perforation, mortality, and ultrastructural changes via electron microscopy.

Main Results:

• Aminophylline (AMN) significantly increased mortality and tissue damage.
• Superoxide dismutase (SOD) administration reduced mortality and protected against bowel infarction and perforation.
• SOD mitigated the detrimental effects of AMN, suggesting O-2 generation by AMN.

Conclusions:

• The injured bowel struggles with reoxygenation following hypoxia.
• Aminophylline (AMN) exacerbates ischemic bowel injury, potentially via O-2 generation.
• Superoxide dismutase (SOD) is a viable therapeutic agent for protecting the bowel during reperfusion injury.